Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kurma Partners is a Paris-based venture capital firm founded in 2009, focusing on investments in the healthcare and biotechnology sectors. The firm has established itself as a significant player in the European venture capital market, managing approximately €890 million in assets under management. Since its inception, Kurma has financed over 72 companies, demonstrating a strong commitment to supporting early-stage ventures.
The firm collaborates closely with leading European research centers, which enhances its ability to foster the development of innovative medical solutions. Kurma Partners has built a reputation for its strategic investments in biotherapies, diagnostics, and deep tech, positioning itself at the forefront of the life sciences sector.
With a dedicated team of professionals, Kurma Partners continues to evolve and adapt to the changing landscape of healthcare and biotechnology, ensuring that it remains a vital resource for startups in these fields.
Kurma Partners primarily invests in the healthcare and biotechnology sectors, targeting early-stage companies across various stages of maturity. Their investment strategy encompasses pre-seed, seed, seed-plus, series A, series B, series C, and growth equity. This broad range allows Kurma to support companies from their inception through to capital expansion.
The firm’s focus areas include biotherapies, diagnostics, and deep tech, which enables them to back a diverse array of innovative solutions within the life sciences. Kurma Partners seeks to collaborate with founders who are passionate about their projects and possess a strong vision for their companies. They emphasize the importance of strategic guidance and access to leading research institutions as key components of their investment approach.
Kurma Partners has a diverse portfolio of 72 companies, showcasing its commitment to the healthcare and biotechnology sectors. Notable companies within their portfolio include:
These companies represent a range of innovative solutions in biotechnology, health technology, and diagnostics, reflecting Kurma's strategic focus on impactful healthcare advancements.
Benjamin Belot - Partner, brings extensive experience in venture capital and has a background in healthcare investments.
Rémi Droller - Managing Partner, has a strong track record in financing biotech companies and previously worked at Rothschild.
Amanda Gett - Partner, specializes in early-stage investments and has a background in life sciences.
Alain Horvais - Partner, focuses on strategic partnerships and has experience in healthcare consulting.
Thierry Laugel - Managing Partner, has a background in investment banking and venture capital.
Peter Neubeck - Partner, brings expertise in deep tech and healthcare investments.
Daniel Parera - Partner, specializes in biotech and has a strong network in the European market.
Philippe Peltier - Partner, focuses on operational support for portfolio companies.
Jean-François Rivassou - Partner, has a background in corporate finance and venture capital.
Hadrien Bouchez - Partner, specializes in healthcare investments and has experience in consulting.
Laura Achach - Associate, supports investment analysis and portfolio management.
Samantha Zennou - Associate, focuses on market research and due diligence.
Florence de Coorebyter - Associate, assists in operational support for portfolio companies.
Anna Tchorzewska - Associate, specializes in financial analysis and reporting.
Maylis Deschamps - Associate, supports investment sourcing and analysis.
Louise-Marie Rakotoarison - Analyst, focuses on data analysis and market trends.
Muriel Domine - General Secretary & Head of Compliance & Legal, oversees legal and compliance matters.
Cyril Bedran - Financial Director, manages financial operations and reporting.
Sonny Guilhem - Senior Financial Controller, oversees financial controls and audits.
Ornella Gomis - Financial Controller, supports financial reporting and analysis.
Steffi Minga - Office Manager, manages office operations and logistics.
Fatima Boubnad - Management Assistant, provides administrative support to the team.
To pitch Kurma Partners, startups should send an email to contact@kurmapartners.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. While specific response times are not guaranteed, founders can expect a timely review of their submissions. Warm introductions are preferred but not mandatory.
As of March 2023, Kurma Partners continues to expand its portfolio, having invested in several promising healthcare and biotechnology startups. The firm remains active in the European venture capital scene, focusing on innovative solutions that address critical health challenges.
In recent months, Kurma has announced new partnerships with leading research institutions to enhance its support for portfolio companies. These collaborations aim to accelerate the development of groundbreaking medical technologies.
What are Kurma Partners' investment criteria?
Kurma Partners invests primarily in early-stage healthcare and biotechnology companies. They focus on sectors such as biotherapies, diagnostics, and deep tech, and prefer to engage with companies at various stages from pre-seed to growth equity.
How can startups apply or pitch to Kurma Partners?
Startups can reach out to Kurma Partners via email at contact@kurmapartners.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Kurma Partners different from other VC firms?
Kurma Partners distinguishes itself through its strong collaboration with leading European research centers, which enhances its ability to support innovative medical solutions. Their focus on healthcare and biotechnology allows them to provide specialized guidance and resources to portfolio companies.
What is the geographic scope of Kurma Partners' investments?
Kurma Partners primarily invests in Europe, focusing on healthcare and biotechnology sectors within this region.
What is the typical check size for investments?
While specific check sizes are not disclosed, Kurma Partners invests across various stages, indicating a flexible approach to funding that can accommodate different capital needs.
What kind of post-investment involvement does Kurma Partners have?
Kurma Partners actively collaborates with its portfolio companies, providing strategic guidance and access to its extensive network within the healthcare and biotechnology sectors to accelerate growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.